{"url_path":"/sec/otlc/8-k/2026-06-29/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/908259/0001493152-26-031124-index.html","accession_number":"0001493152-26-031124","cik":"0000908259","ticker":"OTLC","issuer_name":"Oncotelic Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/908259/0001493152-26-031124-index.html","primary_entity_key":"0000908259","primary_entity_name":"Oncotelic Therapeutics, Inc."},"word_count":20,"has_tables":true,"body_markdown":"**Item\n2.03**\n**Creation\nof a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant**\n\n \n\nSee"}